The effect of SARS-CoV-2 on the development of Parkinson's disease: the role of α-synuclein.
Farideh IravanpourMajid Reza FarrokhiMorteza JafariniaRazieh Tavakoli OliaeePublished in: Human cell (2023)
The current coronavirus disease 2019 (COVID-19) can lead to various neurological complications in infected people. These neurological effects include problems in both central nervous system (CNS) and peripheral nervous system (PNS). Hyposmia, a PNS symptom of COVID-19, frequently manifests in the early stages of Parkinson's disease (PD) and serves as an early warning sign of the condition. In addition, the olfactory system is recognized as an early site for the onset of α-synuclein pathology, the pathological hallmark of PD. PD is characterized by accumulation and aggregation of misfolded α-synuclein (α-Syn) into Lewy bodies and Lewy neurites, resulting in the degeneration of dopaminergic neurons in substantia nigra pars compacta (SNpc). Previous research has also shown the involvement of α-Syn in the innate immune response following viral infections. Consequently, the potential link between viral infections and development of PD has gained attention in recent years. However, it's still too early to definitively conclude whether COVID-19 can cause Parkinsonism. Nevertheless, we can explore the likelihood of this connection by examining past studies and possible mechanisms to better understand how COVID-19 might potentially lead to PD following the infection. Based on the various pieces of evidence discussed in this review, we can infer that SARS-CoV-2 promotes the aggregation of α-Syn and, ultimately, leads to PD through at least two mechanisms: the stable binding of the S1 protein to proteins prone to aggregation like α-Syn, and the upregulation of α-Syn as part of the immune response to the infection.
Keyphrases
- sars cov
- coronavirus disease
- respiratory syndrome coronavirus
- immune response
- parkinson disease
- mental health
- risk factors
- poor prognosis
- spinal cord
- long non coding rna
- toll like receptor
- signaling pathway
- dendritic cells
- brain injury
- drug induced
- deep brain stimulation
- cerebrospinal fluid
- small molecule
- chemotherapy induced